Compare
Regencell Bioscience Holdings Ltd vs Charlie's Holdings, Inc. vs Functional Brands Inc. vs Mannatech Inc
| Latest fiscal year | Regencell Bioscience Holdings Ltd RGC | Charlie's Holdings, Inc. CHUC | Functional Brands Inc. MEHA | Mannatech Inc MTEX |
|---|---|---|---|---|
| Year ended | 2026-06-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $20.92M | $6.61M | $108.04M |
| Revenue growth (YoY) | n/a | +169.4% | +0.7% | -8.3% |
| Gross margin | n/a | 27.0% | 52.7% | 74.9% |
| Operating margin | n/a | -10.4% | -21.2% | -0.4% |
| Net margin | n/a | 21.5% | 11.5% | -14.1% |
| Net income | -$11.70M | $4.50M | $758.5K | -$15.21M |
| EPS (Diluted) | -$2.37 | $0.02 | $0.01 | -$8.00 |
| Operating cash flow | -$7.70M | -$5.78M | -$1.27M | -$2.96M |
| Free cash flow | n/a | -$5.80M | -$1.28M | -$4.32M |
| Cash & equivalents | n/a | n/a | $2.73M | $6.18M |
| Total assets | $14.73M | $11.56M | $9.11M | $29.99M |
| Total liabilities | $1.38M | $8.14M | $7.57M | $35.22M |
| Shareholders' equity | $13.35M | $3.42M | $1.54M | -$5.22M |
| Return on year-end equity | -87.7% | 131.4% | 49.2% | n/a |
| Shares outstanding | n/a | 270.65M | 18.70M | 1.90M |
Revenue, most recent five fiscal years
| Fiscal year | Regencell Bioscience Holdings Ltd | Charlie's Holdings, Inc. | Functional Brands Inc. | Mannatech Inc |
|---|---|---|---|---|
| Latest | n/a | $20.92M Ended 2025-12-31 | $6.61M Ended 2025-12-31 | $108.04M Ended 2025-12-31 |
| 1 year earlier | n/a | $7.76M Ended 2024-12-31 | $6.57M Ended 2024-12-31 | $117.87M Ended 2024-12-31 |
| 2 years earlier | n/a | $16.25M Ended 2023-12-31 | n/a | $131.96M Ended 2023-12-31 |
| 3 years earlier | n/a | $26.42M Ended 2022-12-31 | n/a | $137.21M Ended 2022-12-31 |
| 4 years earlier | n/a | $21.50M Ended 2021-12-31 | n/a | $159.76M Ended 2021-12-31 |